Is the revised International staging system for myeloma valid in a real world population?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Is the revised International staging system for myeloma valid in a real world population?

Published:2016-10-13 Issue:3 Volume:180 Page:451-454
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Walker Ieuan¹,Coady Alice¹,Neat Michael²³,Ladon Darius⁴,Benjamin Reuben⁵⁶,El-Najjar Inas²⁵,Kazmi Majid²⁵,Schey Steve⁵⁶,Streetly Matthew²⁵⁶

Affiliation:

1. Guy's King's and St Thomas' School of Medicine; King's College London; London UK

2. Department of Haematology; Guy's and St Thomas' Hospital Trust; NHS; London UK

3. Department of Cancer Genetics; ViaPath; Guy's and St Thomas' Hospital Trust; NHS; London UK

4. Department of Cytogenetics; Viapath; Kings College Hospital; London UK

5. Kings Health Partners; London UK

6. Department of Haematology; King's College Hospital; London UK

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14341/fullpdf

Reference10 articles.

1. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival;Durie;Cancer,1975

2. International Myeloma Working Group molecular classification of multiple myeloma: spotlight review;Fonseca;Leukemia,2009

3. International staging system for multiple myeloma;Greipp;Journal of Clinical Oncology,2005

4. Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN);Palumbo;Blood,2011

5. Revised International staging system for multiple myeloma: a report from International myeloma working group;Palumbo;Journal of Clinical Oncology,2015

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High‐risk multiple myeloma: Redefining genetic, clinical, and functional high‐risk disease in the era of molecular medicine and immunotherapy;American Journal of Hematology;2024-04-13

2. Early relapse within 18 months is a powerful dynamic predictor for prognosis and could revise static risk distribution in multiple myeloma;Cancer;2023-10-17

3. A risk-scoring system for assessing prognosis in multiple myeloma patients based on a large real-world sample;2023-05-19

4. Heterogeneity in long-term outcomes for patients with Revised International Staging System stage II, newly diagnosed multiple myeloma;Haematologica;2022-09-29

5. Evaluation of prognostic staging systems of multiple myeloma in the era of novel agents;Hematological Oncology;2021-12-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3